How many institutions held CHRS - Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share in Q1 2015?

49 institutional investors reported CHRS - Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share for Q1 2015. Use the holders table for investor-level position and value details.

Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS)

Q: What does CUSIP 19249H103 represent in this 13F holders report?

CUSIP 19249H103 is the security identifier for CHRS - Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share used to aggregate holder disclosures.

CUSIP: 19249H103

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class: Equity / Common Stock, $0.0001 par value per share
Shares outstanding: 153,624,096
Total 13F shares: 7,268,421
Share change: -2,761,692
Total reported value: $221,671,439
Price per share: $30.58
Number of holders: 49
Value change: -$28,139,852
Number of buys: 34
Number of sells: 21

Quarterly Holders Quick Answers

What is CUSIP 19249H103?
CUSIP 19249H103 identifies CHRS - Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2015
Previous quarter: Q4 2014

Recent filing periods for CUSIP 19249H103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of CHRS - Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Kohlberg Kravis Roberts & Co. L.P.	13F	Company	2%	3,055,055	$49,858,000	—	31 Dec 2014	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	1%	1,555,355	$25,383,000	—	31 Dec 2014	13F
FMR LLC	13F	Company	0.77%	1,186,853	$17,311,000	—	31 Dec 2014	13F
VHCP Management, LLC	13F	Company	0.57%	870,269	$13,070,000	—	31 Dec 2014	13F
WESTFIELD CAPITAL MANAGEMENT CO LP	13F	Company	0.51%	778,041	$12,698,000	—	31 Dec 2014	13F
JPMORGAN CHASE & CO	13F	Company	0.48%	735,319	$12,001,000	—	31 Dec 2014	13F
PERCEPTIVE ADVISORS LLC	13F	Company	0.29%	438,000	$7,148,000	—	31 Dec 2014	13F
Rock Springs Capital Management LP	13F	Company	0.16%	240,051	$3,918,000	—	31 Dec 2014	13F
BROWN ADVISORY INC	13F	Company	0.15%	223,900	$3,654,000	—	31 Dec 2014	13F
Cormorant Asset Management, LP	13F	Company	0.14%	222,200	$3,626,000	—	31 Dec 2014	13F
VANGUARD GROUP INC	13F	Company	0.05%	71,682	$1,169,000	—	31 Dec 2014	13F
NORTHERN TRUST CORP	13F	Company	0.05%	69,989	$1,142,000	—	31 Dec 2014	13F
MAZAMA CAPITAL MANAGEMENT INC	13F	Company	0.04%	63,635	$1,039,000	—	31 Dec 2014	13F
MORGAN STANLEY	13F	Company	0.04%	58,769	$959,000	—	31 Dec 2014	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.02%	37,127	$605,000	—	31 Dec 2014	13F
Alyeska Investment Group, L.P.	13F	Company	0.02%	34,183	$558,000	—	31 Dec 2014	13F
STATE STREET CORP	13F	Company	0.02%	32,878	$537,000	—	31 Dec 2014	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.02%	29,115	$475,000	—	31 Dec 2014	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.01%	22,768	$372,000	—	31 Dec 2014	13F
NORGES BANK	13F	Company	0.01%	20,000	$326,000	—	31 Dec 2014	13F
Bank of New York Mellon Corp	13F	Company	0.01%	16,752	$273,000	—	31 Dec 2014	13F
Cubist Systematic Strategies, LLC	13F	Company	0.01%	14,414	$235,000	—	31 Dec 2014	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.01%	13,864	$227,000	—	31 Dec 2014	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.01%	12,700	$207,000	—	31 Dec 2014	13F
E. E. Geduld	13F	Individual	0.01%	10,000	$163,000	—	31 Dec 2014	13F
PNC FINANCIAL SERVICES GROUP, INC.	13F	Company	0%	7,580	$124,000	—	31 Dec 2014	13F
DEUTSCHE BANK AG\	13F	Company	0%	6,331	$103,000	—	31 Dec 2014	13F
TEACHERS ADVISORS, LLC	13F	Company	0%	6,275	$102,000	—	31 Dec 2014	13F
Nationwide Fund Advisors	13F	Company	0%	4,767	$78,000	—	31 Dec 2014	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0%	4,278	$69,817	—	31 Dec 2014	13F
STRS OHIO	13F	Company	0%	2,400	$39,000	—	31 Dec 2014	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0%	1,523	$25,000	—	31 Dec 2014	13F
PRELUDE CAPITAL MANAGEMENT, LLC	13F	Company	0%	1,500	$24,000	—	31 Dec 2014	13F
CITIGROUP INC	13F	Company	0%	1,366	$22,000	—	31 Dec 2014	13F
UBS Group AG	13F	Company	0%	685	$11,000	—	31 Dec 2014	13F
BARCLAYS PLC	13F	Company	0%	388	$6,000	—	31 Dec 2014	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	101	$2,000	—	31 Dec 2014	13F
ROYAL BANK OF CANADA	13F	Company	0%	33	$1,000	—	31 Dec 2014	13F

Institutional Holders of Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS) as of Q1 2015

As of 31 Mar 2015, Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS) was held by 49 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,268,421 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, LLC, JPMORGAN CHASE & CO, VHCP Management, LLC, FMR LLC, MILLENNIUM MANAGEMENT LLC, BROWN ADVISORY INC, COLUMBUS CIRCLE INVESTORS, Cormorant Asset Management, LLC, Rock Springs Capital Management LP, and VANGUARD GROUP INC. This page lists 49 institutional shareholders reporting positions in this security for the Q1 2015 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2015 vs Q4 2014 Across Filers

Q4 2014 holders

Q1 2015 holders

Holder diff

Investor	Q4 2014 Shares	Q1 2015 Shares	Share Diff	Share Chg %	Q4 2014 Value $	Q1 2015 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.